Tenet Healthcare (THC)
(Real Time Quote from BATS)
$135.36 USD
+1.63 (1.22%)
Updated Jul 12, 2024 12:12 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
THC 135.36 +1.63(1.22%)
Will THC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for THC
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
THC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?
Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?
Other News for THC
Deutsche Numis Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Tenet Healthcare price target raised by $5 at Deutsche Bank, here's why
Tenet Healthcare Reaches Analyst Target Price
February 2025 Options Now Available For Tenet Healthcare (THC)
Long-term beneficiaries of AI, according to Goldman Sachs